In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
Editors' Picks of Pharmaceutical Science and Technology Innovations

Pharmaceutical Technology
Volume 34, Issue 4, pp. 26

Analytical instruments assist the pharmaceutical manufacturing process in important ways. The devices can verify the identity and purity of raw materials, determine the appropriate end point of a process such as mixing, and ensure the quality of final dosage forms. Used in process analytics, these devices could one day help to enable the real-time release of finished products. This month's highlighted machines represent new developments in analytical instrumentation. Waters's analyzer can help scientists switch between liquid-chromatography methods. Malvern's light-scattering instrument aids protein characterization. A spectrometer from Hiden enables users to determine the end point of a lyophilization process.

Analytical system enables switch to UPLC


ACQUITY UPLC H-Class system Waters www.waters.com
The ACQUITY UPLC H-Class System from Waters (Milford, MA) uses a format familiar to users of high-performance liquid chromatography (HPLC) to help them switch to ultrahigh performance liquid chromatography (UPLC) methods easily. The system lets scientists transfer methods between HPLC and UPLC seamlessly, according to William Foley, the company's director of LC products.

The flow-through needle design of the system's sample manager supports sample injections from UPLC volumes (e.g., less than 2 μL) to HPLC volumes (e.g., 250 μL). The system's quaternary-solvent manager resembles that of an HPLC system, but provides UPLC performance. The ACQUITY system's active preheater (APH) reduces dispersion and bandspreading, thus enabling high-efficiency separations. The APH also helps scientists transfer methods between systems by ensuring that temperatures are equivalent.

Instrument requires small sample volumes


Zetasizer μV instrument Malvern www.malvern.com
Malvern's (Malvern, England) Zetasizer μV uses dynamic and static light-scattering techniques to characterize proteins. The instrument is designed to provide high sensitivity and yield rapid, accurate, and repeatable protein-size and molecular-weight data. The Zetasizer μV requires samples of only 2 μL, and a sample can be recovered fully after the measurement. Because of the small sample size required and the unit's high sensitivity, the instrument can analyze small quantities of protein. For example, the Zetasizer μV can measure 40 ng of bovine serum albumin.

Spectrometer enables real-time analysis


Transient mass spectrometer Hiden Analytical www.hidenanalytical.com
The Transient mass spectrometer from Hiden Analytical (Warrington, England) includes pulse ion-counting detection and a heated, silica-lined, capillary-sampling inlet to provide results in less than 150 ms. The instrument enables real-time quantitative analysis and responds to gas-composition changes that are smaller than the parts-per-million (ppm) scale. The instrument offers as many as 500 measurement points per second.

The analyzer's heated, viscous-flow capillary and fittings with low dead volumes enable its fast response times. The unit includes a HAL 3F/PIC mass spectrometer that offers 32-bit counting, thus providing a seven-decade continuous dynamic range that enables rapid analysis at concentrations at the ppm scale. The spectrometer's data-acquisition program records and displays information quickly. The program includes a soft-ionization mode for analyzing complex mixtures and a quantitative-analysis mode. Scientists can use the spectrometer to determine the end point of the lyophilization process and analyze solvents, water vapor, and air gases.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here